Real Brokerage’s Growth Surges 400% Under Leadership of Sharran SrivatsaaCloud-based real estate firm outpaces industry trends, adding 20,000 agents in just over two years despite market headwinds.
Garth Coates Solicitors Reports Fivefold Increase in American Interest in UK Business MigrationUnited Kingdom, April 26, 2025 -- UK-based immigration law firm Garth Coates Solicitors ( www.garthcoates.com ) has reported a fivefold increase in enquiries from American nationals seeking relocation to the United Kingdom through business-led immigration pathways.
EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital
EyeMD EMR Healthcare Systems, Inc., (“EyeMD EMR” or “the Company”), a leading provider of healthcare technology software solutions purpose-built for ophthalmologists and eye care specialists, announced a significant majority growth investment from Performant Capital, a Chicago-based private equity firm focused on partnering with and scaling software and technology-enabled businesses.
Best Bitcoin Casino 2025 Rankings ReleasedWireDaily Reveals the Top Bitcoin Casinos to Watch in 2025
UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigational Treatment for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced an updated 18-month DOR of 80.6% (95% CI: 74.0, 85.7), by Kaplan-Meier estimate, from the Phase 3 ENVISION trial of UGN-102 (mitomycin) for intravesical solution, an investigational treatment for recurrent LG-IR-NMIBC. These data were featured today in an Oral Presentation Session (Abstract ID: PD12) at the AUA 2025 Annual Meeting in Las Vegas, Nevada.
Fencing Contractors and Fence Builders: Top Fencing Services for Your PropertyLooking for reliable fencing contractors and expert fence builders? Our top-quality fencing services are perfect for your property. Contact us today for a consultation and expert advice. Call 022 383 4966 for more information and to get started on your fencing project.
Este Medical Group Introduces Innovative Exosome Hair Loss Therapy to BirminghamBirmingham, United Kingdom--(Newsfile Corp. - April 26, 2025) - Este Medical Group Birmingham, a leader in hair restoration and cosmetic...
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against AppLovin CorporationSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline for Securities Fraud Class Action Lawsuit Filed Against AppLovin CorporationRADNOR, PA - April 26, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against AppLovin Corporation (“AppLovin”) (
NASDAQ: APP) on behalf of those who purchased or otherwise acquired AppLovin securities between May 10, 2023, and March 26, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 5, 2025.
Studies Uncover Hidden Urologic Risks—How Water, Chemicals and Everyday Exposures Impact Urinary HealthLAS VEGAS, April 26, 2025 (GLOBE NEWSWIRE) -- Groundbreaking research presented at the American Urological Association (AUA) Annual Meeting in Las Vegas is shining a spotlight on the hidden environmental factors influencing urinary health.
Website Featuring Motivational Christian Quotes By Famous Evangelists LaunchedA renowned Christian author known for books on prophecy has launched a website dedicated to motivational quotes from famous Christians.
Motivational Christian Quotes to Boost Faith: Vince Baker Launches New WebsiteVince Baker Ministries has launched a new website featuring motivational Christian quotes and blog content to inspire spiritual growth.
Motivational Christian Quotes to Inspire Believers: Vince Baker Launches WebsiteVince Baker Ministries launches a new website featuring inspirational Christian quotes from famous figures, offering encouragement and spiritual growth for believers.
Homeowner Thrilled with Right Way Roofing and Lead Installer SergioA local homeowner is thrilled with the outstanding service from Right Way Roofing and lead installer Sergio. From start to finish, the experience was smooth, professional, and stress-free. Thanks to Sergio’s expert work and the team's dedication, the homeowner now enjoys a beautiful, reliable new roof — and complete peace of mind.
ACA Enrollees Face Growing Coverage Crisis: Black Book Survey Signals Rising Fears Amid Economic Instability and Proposed Healthcare RollbacksNationwide Poll Finds Overwhelming Opposition to ACA Policy Changes, Escalating Financial Vulnerability, and Strong Public Demand for Expanded Healthcare Access
Pickleball Backhand For Beginners, 2025 Tips and Strategies Guide UpdatedFor newcomers looking to get in on the pickleball boom, Mastering Pickleball Basics offers free guides to every aspect of game play, now refreshed with new information on the basics - including forehand and backhand form and basic shots.
RAINN Statement on the Passing of Virginia GiuffreWashington, D.C., April 26, 2025 (GLOBE NEWSWIRE) -- Today, RAINN, the nation’s largest anti-sexual violence organization, isssued the following statement upon the news that Virginia Giuffre, who bravely brought forth allegations of sexual abuse against Jeffrey Epstein and his associates, passed away:
Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
Pfizer Inc. (
NYSE: PFE) today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus Calmette-Guérin (BCG) as induction therapy with or without maintenance in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer (NMIBC). The trial met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a clinically meaningful and statistically significant improvement with sasanlimab in combination with BCG (induction and maintenance) as compared to BCG alone (induction and maintenance): Hazard Ratio (HR) of 0.68; 95% Confidence Interval (CI), 0.49-0.94; 2-sided p=0.019; median EFS not yet reached. These findings show a 32% reduction in risk of disease-related events, including high-grade disease recurrence or progression, with the sasanlimab combination regimen as compared with SOC treatment alone. Pre-specified subgroup analyses for patients harboring higher risk disease showed consistent benefit with EFS HR of 0.63 (0.41, 0.96) for T1 disease, and EFS HR 0.53 (0.29, 0.98) for those with CIS disease.
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French AuthoritiesSaint Herblain (France), April 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation for use of Valneva’s single-dose chikungunya vaccine IXCHIQ® for the prevention of disease caused by the chikungunya virus (CHIKV) following reports of serious adverse events (SAEs) in elderly people with comorbidities during the ongoing vaccination campaign in La Reunion and Mayotte. Valneva has been responding to the French government’s call for vaccine supply of IXCHIQ® in La Reunion1 as the island is going through a major chikungunya outbreak with ~ 40,000 confirmed cases since the beginning of 20252.
Studies Unveil Groundbreaking Advances in Prostate Cancer: From AI-Driven Detection to Non-Invasive TestingLAS VEGAS, April 26, 2025 (GLOBE NEWSWIRE) -- Abstracts presented at this year's American Urological Association (AUA) Annual Meeting in Las Vegas will spotlight a series of innovative research studies poised to transform prostate cancer care.
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of The BancorpFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Bancorp To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of TFI InternationalFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In TFI To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Open LendingFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Open Lending To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ready CapitalFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ready Capital To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciencesFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Maravai LifeSciences To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of NET PowerFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In NET Power To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Manhattan AssociatesFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Manhattan Associates To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of e.l.f. BeautyFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In e.l.f. Beauty To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Lab USAFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Rocket Lab To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of EverusFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Everus To Contact Him Directly To Discuss Their Options
Studies Show Breakthroughs in Male Contraception, Including First Male Contraceptive HydrogelLAS VEGAS, April 26, 2025 (GLOBE NEWSWIRE) -- Groundbreaking research presented at the American Urological Association (AUA) Annual Meeting in Las Vegas is ushering in a new era for men’s reproductive health.
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace MedicalFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Treace Medical To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BigBear.aiFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BigBear.ai To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AppLovinFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AppLovin To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana BiotechnologyFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sana To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Perpetua Resources Corp.Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Perpetua To Contact Him Directly To Discuss Their Options
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ViatrisFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Viatris To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bakkt HoldingsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bakkt To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ultra CleanFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ultra Clean To Contact Him Directly To Discuss Their Options
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SkyworksFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Skyworks To Contact Him Directly To Discuss Their Options
TBBK CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors - a Securities Fraud Class Action Lawsuit Has Been Filed Against The Bancorp, Inc. (TBBK)RADNOR, PA - April 26, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against The Bancorp, Inc. (“Bancorp”) (
NASDAQ: TBBK) on behalf of those who purchased or otherwise acquired Bancorp securities between January 25, 2024, and March 4, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 16, 2025.
